- Home
- NVCR vs TBBK Comparison
NVCR vs TBBK Comparison
Compare NVCR & TBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- TBBK
- Stock Information
- Founded
- NVCR 2000
- TBBK 1999
- Country
- NVCR Jersey
- TBBK United States
- Employees
- NVCR N/A
- TBBK N/A
- Industry
- NVCR Medical/Dental Instruments
- TBBK Major Banks
- Sector
- NVCR Health Care
- TBBK Finance
- Exchange
- NVCR Nasdaq
- TBBK Nasdaq
- Market Cap
- NVCR 1.8B
- TBBK 2.7B
- IPO Year
- NVCR 2015
- TBBK 2004
- Fundamental
- Price
- NVCR $17.49
- TBBK $50.58
- Analyst Decision
- NVCR Buy
- TBBK Buy
- Analyst Count
- NVCR 5
- TBBK 3
- Target Price
- NVCR $26.60
- TBBK $55.00
- AVG Volume (30 Days)
- NVCR 1.3M
- TBBK 564.7K
- Earning Date
- NVCR 10-30-2024
- TBBK 10-24-2024
- Dividend Yield
- NVCR N/A
- TBBK N/A
- EPS Growth
- NVCR N/A
- TBBK 16.52
- EPS
- NVCR N/A
- TBBK 3.95
- Revenue
- NVCR $549,964,000.00
- TBBK $472,015,000.00
- Revenue This Year
- NVCR $16.23
- TBBK N/A
- Revenue Next Year
- NVCR $6.09
- TBBK $7.05
- P/E Ratio
- NVCR N/A
- TBBK $12.71
- Revenue Growth
- NVCR 8.33
- TBBK 6.71
- 52 Week Low
- NVCR $10.87
- TBBK $29.92
- 52 Week High
- NVCR $24.74
- TBBK $59.26
- Technical
- Relative Strength Index (RSI)
- NVCR 43.24
- TBBK 44.27
- Support Level
- NVCR $15.61
- TBBK $45.82
- Resistance Level
- NVCR $17.31
- TBBK $59.26
- Average True Range (ATR)
- NVCR 1.29
- TBBK 2.17
- MACD
- NVCR 0.05
- TBBK -0.96
- Stochastic Oscillator
- NVCR 11.59
- TBBK 35.86
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About TBBK The Bancorp Inc
The Bancorp Inc is a financial holding company, through its subsidiary it is engaged in specialty lending namely securities-backed lines of credit, vehicle fleet and another equipment leasing, Small Business Administration lending, insurance policy cash value-backed lines of credit and commercial mortgage-backed loans, generated for sale into commercial mortgage-backed securities markets through securitizations. The company deposits and non-interest income are generated in the payments business which consists of issuing, acquiring, and automated clearing house accounts.